Case Report: Successful management of refractory palmoplantar pustulosis with upadacitinib

Authors: Boyun Yang, Hanxiao Yu, Wo Yao, Huiying Wang

Source: Frontiers in Immunology, Vol 16 (2025)

Subject Terms: palmoplantar pustulosis, anti-IgE, upadacitinib, Janus kinase inhibitors, cytokines, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2025.1476584/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/c9d74368d51f4eca8aa38e0adb018b90

Omalizumab is ineffective in regulating proasthmatic serum cytokine and chemokine levels in nonresponders with high BMI

Authors: Agnes Yang, BS, Chao Gu, PhD, Katherine Upchurch, PhD, Adrien Caffiers, MS, Mark Millard, MD, Laurie Baert, PhD, HyeMee Joo, PhD, SangKon Oh, PhD

Source: Journal of Allergy and Clinical Immunology: Global, Vol 4, Iss 2, Pp 100462- (2025)

Subject Terms: Asthma, IgE, anti-IgE, omalizumab, serum, cytokine, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2772829325000633; https://doaj.org/toc/2772-8293

Access URL: https://doaj.org/article/9c7cee051c8e415bad6448f813c426eb

Evaluation of Serum Zonulin Level and Intestinal Permeability in Patients with Chronic Spontaneous Urticaria and the Relationship Between Serum Zonulin Level and Disease Severity

Authors: Simge Ünal, Selda Pelin Kartal, Ahmet Ozsoy, Fevzi Nuri Aydın

Source: Dermatology Practical & Conceptual, Vol 15, Iss 1 (2025)

Subject Terms: Chronic Spontaneous Urticaria, Autoimmune Urticaria, anti-IgE, Intestinal Permeability, Zonulin, Dermatology, RL1-803

File Description: electronic resource

Relation: https://dpcj.org/index.php/dpc/article/view/4237; https://doaj.org/toc/2160-9381

Access URL: https://doaj.org/article/eaef502374d64a618fb9b900ba1fa0e1

Use of omalizumab and allergen-specific immunotherapy for the treatment of respiratory allergic diseases in children and adults

Authors: A. S. Prilutskiy, O. A. Prilutskaia

Source: Аллергология и Иммунология в Педиатрии, Vol 0, Iss 2, Pp 38-49 (2024)

Subject Terms: allergen-specific immunotherapy, children, adults, omalizumab, biological drugs, anti-ige therapy, rhinitis, asthma, allergens, treatment, Pediatrics, RJ1-570

File Description: electronic resource

Relation: https://adair.elpub.ru/jour/article/view/145; https://doaj.org/toc/2500-1175; https://doaj.org/toc/2712-7958

Access URL: https://doaj.org/article/37c05af7d0d24d2e8b65eea45bd9d499

Anti-IgE therapy in chronic rhinosinusitis with nasal polyps

Authors: Chhiba, Krishan D., Patel, Gayatri B., Peters, Anju T. ^∗

Source: In The Journal of Allergy and Clinical Immunology January 2025 155(1):24-30

Updated review of omalizumab to treat uncontrolled pediatric allergic asthma

Authors: Chipps, Bradley E. ^{a, ∗}, Garcia, Meghan Farrell ^a, Murphy, Kevin R. ^b, Haselkorn, Tmirah ^c

Source: In The Journal of Allergy and Clinical Immunology January 2025 155(1):12-23

Anti-IgE and food allergy

Authors: Dantzer, Jennifer A. ^∗, Wood, Robert A.

Source: In The Journal of Allergy and Clinical Immunology January 2025 155(1):1-11

Omalizumab with allergen immunotherapy in respiratory & food allergy

Authors: Kathuria, P.C. ^{a, ⁎}, Rai, Manisha ^b

Source: In Indian Journal of Tuberculosis January 2025 72(1):98-102

A practical guide for implementing omalizumab therapy for food allergy

Authors: Casale, Thomas B. ^{a, ∗}, Fiocchi, Alessandro ^b, Greenhawt, Matthew ^c

Source: In The Journal of Allergy and Clinical Immunology June 2024 153(6):1510-1517

Omalizumab as a long-term treatment for patients with severe asthma. Is it safe?: A ten-year study

Authors: Mohamed Habeb, Abeer Elhawary, Mohamed S Hamed, Niveen E Zayed

Source: Egyptian Journal of Chest Disease and Tuberculosis, Vol 73, Iss 1, Pp 7-12 (2024)

Subject Terms: anti-ige, long-term treatment and side effects, omalizumab, safety, severe asthma, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2024;volume=73;issue=1;spage=7;epage=12;aulast=Habeb; https://doaj.org/toc/0422-7638; https://doaj.org/toc/2090-9950

Access URL: https://doaj.org/article/56231228d7cc436586e8bd7a419dab90

Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review

Authors: Cuihong Cai, Jingjing Qu, Jianying Zhou

Source: BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-8 (2023)

Subject Terms: Allergic bronchopulmonary aspergillosis, anti-IgE antibody, Omalizumab, Allergic rhinitis, Total serum IgE level, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2466

Access URL: https://doaj.org/article/51fbb47cf2d540338b1657f1df6b545a

Phenotypes and endotypes in asthma-practical approach

Authors: P.C. Kathuria, Manisha Rai

Source: Indian Journal of Allergy Asthma and Immunology, Vol 38, Iss 1, Pp 1-2 (2024)

Subject Terms: allergen immunotherapy, anti-ige, asthma, benralizumab, early-onset asthma, endotypes, late-onset asthma, mepolizumab, omalizumab, phenotypes, t2-asthma, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://journals.lww.com/10.4103/ijaai.ijaai_5_24; https://doaj.org/toc/0972-6691; https://doaj.org/toc/2320-4745

Access URL: https://doaj.org/article/a1b9f6f1d9af4298867ff0cb5b227600

A robust mRNA signature obtained via recursive ensemble feature selection predicts the responsiveness of omalizumab in moderate‐to‐severe asthma

Authors: Sarah Kidwai, Pietro Barbiero, Irma Meijerman, Alberto Tonda, Paula Perez‐Pardo, Pietro Lio ́, Anke H. van derMaitland‐Zee, Daniel L. Oberski, Aletta D. Kraneveld, Alejandro Lopez‐Rincon

Source: Clinical and Translational Allergy, Vol 13, Iss 11, Pp n/a-n/a (2023)

Subject Terms: anti‐IgE, asthma, biomarker, machine‐learning, omalizumab, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://doaj.org/toc/2045-7022

Access URL: https://doaj.org/article/dc82ea5a34754f9ab2041cdf4636cd31

Analysis of predictors of response to anti-IgE therapy in patients with severe atopic bronchial asthma in real clinical practice

Authors: Daria S. Fomina, Olga A. Mukhina, Marina S. Lebedkina, Mirada K. Gadzhieva, Elena N. Bobrikova, Dmitry O. Sinyavkin, Vasiliy V. Parshin, Anton A. Chernov, Andrey S. Belevskiy

Source: Терапевтический архив, Vol 94, Iss 3, Pp 413-419 (2022)

Subject Terms: anti-ige therapy, omalizumab, predictors of non-response, severe atopic asthma, Medicine

File Description: electronic resource

Relation: https://ter-arkhiv.ru/0040-3660/article/viewFile/106468/80891; https://doaj.org/toc/0040-3660; https://doaj.org/toc/2309-5342

Access URL: https://doaj.org/article/af3d9eb1ce6446daa7ece9b26896ff20

Expression and existence forms of mast cell activating molecules and their antibodies in systemic lupus erythematosus

Authors: Yuping Wang, Tengkai Wang, Meijuan Cai, Shuzhen Zhu, Lijun Song, Qian Wang

Source: Immunity, Inflammation and Disease, Vol 10, Iss 2, Pp 235-240 (2022)

Subject Terms: Anti‐FcεRI, Anti‐IgE, FcεRIα, IgE, SLE, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://doaj.org/toc/2050-4527

Access URL: https://doaj.org/article/8357f446c56244aa86416f32297426d2

Severe pediatric asthma therapy: Omalizumab—A systematic review and meta-analysis of efficacy and safety profile

Authors: Grazia Fenu, Andrea La Tessa, Claudia Calogero, Enrico Lombardi

Source: Frontiers in Pediatrics, Vol 10 (2023)

Subject Terms: anti-IgE, severe asthma, children, randomized controlled trial, systematic review, Pediatrics, RJ1-570

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fped.2022.1033511/full; https://doaj.org/toc/2296-2360

Access URL: https://doaj.org/article/1435cef5e04442d486d5f78ec3a6bdec

IgE-immunoadsorption for severe allergy to multiple foods: A case series of five children

Authors: Stefania Arasi, MD, PhD, MSC, Anna Lucia Piscitelli, MD, Arianna Cafarotti, MD, Beatrice Marziani, MD, Valentina Pecora, MD, Lamia Dahdah, MD, Giovanna Leone, MD, Giorgia Bracaglia, PhD, Ottavia Porzio, MD, Andrea Onetti Muda, MD, Alessandro Fiocchi, MD

Source: World Allergy Organization Journal, Vol 16, Iss 2, Pp 100750- (2023)

Subject Terms: Anti-IgE treatment, Children, IgE-immunoadsorption, Omalizumab, Severe food allergy, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1939455123000108; https://doaj.org/toc/1939-4551

Access URL: https://doaj.org/article/ebef6eda74fb4dd79c453f88bb0c8b47

Omalizumab for the management of refractory chronic spontaneous urticaria

Authors: P C Kathuria, Manisha Rai

Source: Indian Journal of Allergy Asthma and Immunology, Vol 36, Iss 2, Pp 65-72 (2022)

Subject Terms: chronic inducible urticaria, chronic spontaneous urticaria, chronic urticaria, ligelizumab, omalizumab (anti-ige), urticaria activity score, urticaria control test, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: http://www.ijaai.in/article.asp?issn=0972-6691;year=2022;volume=36;issue=2;spage=65;epage=72;aulast=Kathuria; https://doaj.org/toc/0972-6691

Access URL: https://doaj.org/article/2e6093436d864eeb95f691164d2f91b9

Current State of Monoclonal Antibody Therapy for Allergic Diseases

Authors: Yan Chen, Wei Wang, Huihui Yuan, Yan Li, Zhe Lv, Ye Cui, Jie Liu, Sun Ying

Source: Engineering, Vol 7, Iss 11, Pp 1552-1556 (2021)

Subject Terms: Allergic disease, Monoclonal antibody, Anti-IgE, Cytokines, Clinical trials, Engineering (General). Civil engineering (General), TA1-2040

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2095809921002228; https://doaj.org/toc/2095-8099

Access URL: https://doaj.org/article/439aeb64698d4fff9387319ada27ab5f

Self-reactive IgE and anti-IgE therapy in autoimmune diseases

Authors: Anna Olewicz-Gawlik, Arleta Kowala-Piaskowska

Source: Frontiers in Pharmacology, Vol 14 (2023)

Subject Terms: Immunoglobulin E, anti-IgE, omalizumab, autoimmunity, autoimmune disease, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2023.1112917/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/4f3a4f478b75472b9320a434c9c985de